Defining conditions for biofilm inhibition and eradication assays for Gram-positive clinical reference strains

Cristina D. Cruz; Shreya Shah; Paivi Tammela

doi:10.1186/s12866-018-1321-6

Defining conditions for biofilm inhibition and eradication assays for Gram-positive clinical reference strains

Cristina D. Cruz, Shreya Shah, Paivi Tammela

Forskningsoutput: Tidskriftsbidrag › Artikel › Vetenskaplig › Peer review

Originalspråk	engelska
Artikelnummer	173
Tidskrift	BMC Microbiology
Volym	18
Antal sidor	9
ISSN	1471-2180
DOI	https://doi.org/10.1186/s12866-018-1321-6
Status	Publicerad - 3 nov. 2018
MoE-publikationstyp	A1 Tidskriftsartikel-refererad

Vetenskapsgrenar

1183 Växtbiologi, mikrobiologi, virologi
317 Farmaci

Åtkomst av dokument

10.1186/s12866-018-1321-6Licens: CC BY

12866-018-1321-6Slutlig publicerad version, 1,13 MBLicens: CC BY

New antimicrobials against Gram-positive bacteria
Tammela, P. (Projektledare) & Durante Cruz, C. (Deltagare)
01/10/2016 → 30/09/2018
Projekt: Forskningsprojekt
Phenotypic biosensor-based HTS and mode of action analysis by metabolomics and transcriptomics for enhancing antimicrobial drug discovery against Gram-negative bacteria
Tammela, P. (Principal Investigator)
01/09/2014 → 31/08/2019
Projekt: Forskningsprojekt

Citera det här

@article{3832bd88b4744f6288cd19399de26cb4,

title = "Defining conditions for biofilm inhibition and eradication assays for Gram-positive clinical reference strains",

keywords = "Biofilm, Media, Glucose, Gram-positive bacteria, Crystal violet, Resazurin, Ciprofloxacin, Linezolid, MBIC, MBEC, STAPHYLOCOCCUS-AUREUS BIOFILMS, THROUGHPUT SCREENING ASSAYS, ENTEROCOCCUS-FAECALIS, MICROBIAL BIOFILMS, MICROTITER PLATES, IN-VITRO, QUANTIFICATION, RESAZURIN, ANTIBACTERIAL, GELATINASE, 1183 Plant biology, microbiology, virology, 317 Pharmacy",

author = "Cruz, {Cristina D.} and Shreya Shah and Paivi Tammela",

year = "2018",

month = nov,

day = "3",

doi = "10.1186/s12866-018-1321-6",

language = "English",

volume = "18",

journal = "BMC Microbiology",

issn = "1471-2180",

publisher = "BMC",

}

TY - JOUR

T1 - Defining conditions for biofilm inhibition and eradication assays for Gram-positive clinical reference strains

AU - Cruz, Cristina D.

AU - Shah, Shreya

AU - Tammela, Paivi

PY - 2018/11/3

Y1 - 2018/11/3

KW - Biofilm

KW - Media

KW - Glucose

KW - Gram-positive bacteria

KW - Crystal violet

KW - Resazurin

KW - Ciprofloxacin

KW - Linezolid

KW - MBIC

KW - MBEC

KW - STAPHYLOCOCCUS-AUREUS BIOFILMS

KW - THROUGHPUT SCREENING ASSAYS

KW - ENTEROCOCCUS-FAECALIS

KW - MICROBIAL BIOFILMS

KW - MICROTITER PLATES

KW - IN-VITRO

KW - QUANTIFICATION

KW - RESAZURIN

KW - ANTIBACTERIAL

KW - GELATINASE

KW - 1183 Plant biology, microbiology, virology

KW - 317 Pharmacy

U2 - 10.1186/s12866-018-1321-6

DO - 10.1186/s12866-018-1321-6

M3 - Article

SN - 1471-2180

VL - 18

JO - BMC Microbiology

JF - BMC Microbiology

M1 - 173

ER -

Defining conditions for biofilm inhibition and eradication assays for Gram-positive clinical reference strains

Vetenskapsgrenar

Åtkomst av dokument

Projekt

New antimicrobials against Gram-positive bacteria

Phenotypic biosensor-based HTS and mode of action analysis by metabolomics and transcriptomics for enhancing antimicrobial drug discovery against Gram-negative bacteria

Citera det här